Daliresp
- Product NDC
- 55154-4625
- 11-digit product format
- 551544625
- Labeler code
- 55154
- Product ID
- 55154-4625_c4271d86-cc5f-4ed0-bf0d-fefcd6aa1e77
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- roflumilast
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cardinal Health
- Application
- NDA022522
- Marketing category
- NDA
- Marketing start
- 2011-02-28
- Marketing end
- 0000-00-00
- Substance
- ROFLUMILAST
- Active strength
- 500 ug/1
- Pharmacologic classes
- Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record